Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fortin

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Investigational New Drugs|March 19, 2015
Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat modelMinghan Shi, David Fortin, Léon Sanche, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 13, 2014
Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruptionMarie Blanchette, Luc Tremblay, Martin Lepage, et al.
Cancer|January 11, 2007
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasisDavid Fortin, Cathy Gendron, Marie Boudrias, et al.
Frontiers in Neurology|May 16, 2022
Superior Longitudinal Fasciculus: A Review of the Anatomical Descriptions With Functional CorrelatesFelix Janelle, Christian Iorio-Morin, Sabrina D'amour, et al.
Cancer Genetics and Cytogenetics|September 10, 2009
Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?Macoura Gadji, David Fortin, Ana-Maria Tsanaclis, et al.
AJNR. American Journal of Neuroradiology|May 14, 2004
Technical modification in the intracarotid chemotherapy and osmotic blood-brain barrier disruption procedure to prevent the relapse of carboplatin-induced orbital pseudotumorDavid Fortin, Joseph A Salamé, Annick Desjardins, et al.
Biomolecules|March 28, 2025
Optimization of Intra-Arterial Administration of Chemotherapeutic Agents for Glioblastoma in the F98-Fischer Glioma-Bearing Rat ModelJuliette Latulippe, Laurent-Olivier Roy, Fernand Gobeil, et al.
Journal of Neuro-Oncology|September 13, 2013
Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brainGabriel Charest, Léon Sanche, David Fortin, et al.
International Journal of Molecular Sciences|November 27, 2021
Chemoattraction of Neoplastic Glial Cells with CXCL10, CCL2 and CCL11 as a Paradigm for a Promising Therapeutic Approach for Primary Brain TumorsLaurence Déry, Gabriel Charest, Brigitte Guérin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapyGabriel Charest, Léon Sanche, David Fortin, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Investigational New Drugs|March 19, 2015
Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat modelMinghan Shi, David Fortin, Léon Sanche, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 13, 2014
Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruptionMarie Blanchette, Luc Tremblay, Martin Lepage, et al.
Cancer|January 11, 2007
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasisDavid Fortin, Cathy Gendron, Marie Boudrias, et al.
Frontiers in Neurology|May 16, 2022
Superior Longitudinal Fasciculus: A Review of the Anatomical Descriptions With Functional CorrelatesFelix Janelle, Christian Iorio-Morin, Sabrina D'amour, et al.
Cancer Genetics and Cytogenetics|September 10, 2009
Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?Macoura Gadji, David Fortin, Ana-Maria Tsanaclis, et al.
AJNR. American Journal of Neuroradiology|May 14, 2004
Technical modification in the intracarotid chemotherapy and osmotic blood-brain barrier disruption procedure to prevent the relapse of carboplatin-induced orbital pseudotumorDavid Fortin, Joseph A Salamé, Annick Desjardins, et al.
Biomolecules|March 28, 2025
Optimization of Intra-Arterial Administration of Chemotherapeutic Agents for Glioblastoma in the F98-Fischer Glioma-Bearing Rat ModelJuliette Latulippe, Laurent-Olivier Roy, Fernand Gobeil, et al.
Journal of Neuro-Oncology|September 13, 2013
Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brainGabriel Charest, Léon Sanche, David Fortin, et al.
International Journal of Molecular Sciences|November 27, 2021
Chemoattraction of Neoplastic Glial Cells with CXCL10, CCL2 and CCL11 as a Paradigm for a Promising Therapeutic Approach for Primary Brain TumorsLaurence Déry, Gabriel Charest, Brigitte Guérin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapyGabriel Charest, Léon Sanche, David Fortin, et al.
Pageof 9